Statement of the Problem: Squamous cell carcinomas (SCCs) and premalignant disorders such as leukoplakia are common oral cavity lesions. Although these lesions are epithelial in nature, they are also associated with juxta-epithelial chronic inflammation. Mast cells play a significant role in inflammation initiation and propagation.
Purpose: Previous studies have yielded conflicting results in this field. Therefore, this research aimed to assess the number of mast cells in oral SCC and dysplastic leukoplakia and explore their possible role in these lesions.
Materials and Method: In this retrospective cross-sectional study, sixty-three archival cases, including 22 OSCCs, 28 dysplastic leukoplakias as epithelial dysplasia (ED), and 13 normal oral mucosal tissues, were examined for mast cells, using toluidine blue staining. Hotspot areas were identified at 10× magnification and mast cells were counted in 5 fields at 40× magnification. The average cell numbers were calculated, and the severity of inflammation was scored. Statistical analysis was performed using SPSS statistical software 20, including One-way ANOVA, Two-way ANOVA, paired-t test, and independent t-test. p Value < 0.05 was considered significant.
Results: Among the 51 pathologic lesions, 54.9% were males and 45.1% were females, with a mean age of 56.34±15.35 years. The most common locations were the tongue and buccal mucosa. The mast cell count was significantly lower in SCC compared to ED (p= 0.009). There was no correlation between mast cell count and inflammation score (p= 0.345).
Conclusion: In this study, the mast cell count was higher in ED compared to OSCC, sugg-esting an increase in these cells during the pre-malignant stages. However, the number of mast cells decreased after connective tissue invasion and microenvironmental changes occurred. |
- Gupta S, Jawanda MK, Madhushankari GS. Current challenges and the diagnostic pitfalls in the grading of epithelial dysplasia in oral potentially malignant disorders: A review. J Oral Biol Craniofac Res. 2020; 10: 788-799.
- Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008; 37: 127-133.
- Woo SB. Oral Epithelial dysplasia and premalignancy. Head Neck Pathol. 2019; 13: 423-439.
- Da*Silva GDG, Pinheiro TN. Histomorphometric comparative analysis between the oral mucosa of fibrous inflammatory hyperplasia and oral leukoplakia. Transl Cancer Res. 2020; 9: 3101-3106.
- Jaafari*Ashkavandi Z, Moshref M, Mashhadi-Abbas F, Sargolzaie S, Taghavi N. Evaluation of CD31 expression and mast cell count in dysplastic lesions and squamous cell carcinoma of the oral cavity. Iran Red Cres Med J 2010; 12: 272-276.
- Farahani SS, Navabazam A, Ashkevari FS. Comparison of mast cells count in oral reactive lesions. Pathol Res Pract. 2010; 206: 151-155.
- Gudiseva S, Santosh ABR, Chitturi R, Anumula V, Poosarla C, Baddam VRR. The role of mast cells in oral squamous cell carcinoma. Contemp Oncol (Pozn). 2017; 21: 21-29.
- Shrestha A, Keshwar S, Raut T. Evaluation of mast cells in oral potentially malignant disorders and oral squamous cell carcinoma. Int J Dent. 2021; 2021: 5609563.
- Singh S, Gupta V, Vij R, Aggarwal R, Sharma B, Nagpal M. Evaluation of mast cells in oral premalignant and malignant lesions: A histochemical study. Natl J Maxillofac Surg. 2018; 9: 184-190.
- Dantas RCM, de*Souza RO, Valverde LF, Vidal MTA, Sales CBS, Sousa LP, et al. Evaluation of mast cell density in the tumor microenvironment in oral epithelial dysplasia and oral squamous cell carcinoma. Appl Immunohistochem Mol Morphol. 2017; 25: e83-e88.
- Oliveira-Neto HH, Leite AF, Costa NL, Alencar RC, Lara VS, Silva TA, et al. Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells. Oral Oncol. 2007; 43: 484-490.
- Pereira NDS, Pinheiro TN. Histomorphometric comparative analysis between oral dysplastic potentially malignant disorders and oral squamous cell carcinoma. Eur J Dent. 2019; 13: 1-4.
- Iamaroon A, Pongsiriwet S, Jittidecharaks S, Pattanaporn K, Prapayasatok S, Wanachantararak S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med. 2003; 32: 195-199.
- Michailidou EZ, Markopoulos AK, Antoniades DZ. Mast cells and angiogenesis in oral malignant and premalignant lesions. Open Dent J. 2008; 2: 126-132.
- Sharma B, Sriram G, Saraswathi TR, Sivapathasundharam B. Immunohistochemical evaluation of mast cells and angiogenesis in oral squamous cell carcinoma. Indian J Dent Res. 2010; 21: 260-265.
- Tomita M, Matsuzaki Y, Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg. 2000; 69: 1686-1690.
- Schadendorf D, Kohlmus C, Gawlik C, Suter L, Czarnetzki BM. Mast cells in melanocytic tumours. Arch Dermatol Res. 1995; 287: 452-456.
- Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999; 13: 1382-1397.
- Rojas IG, Spencer ML, Martínez A, Maurelia MA, Rudolph MI. Characterization of mast cell subpopulations in lip cancer. J Oral Pathol Med. 2005; 34: 268-273.
- Pujari R, Vidya N. Mast cell density in oral submucous fibrosis: a possible role in pathogenesis. Int J Health Sci (Qassim). 2013; 7: 23-29.
- Santana T, Nagata G, Saturno JL, Trierveiler M. Histopathological features of photodamage and mast cell infiltrate in actinic cheilitis with different grades of epithelial dysplasia. J Cutan Pathol. 2020; 47: 592-600.
- Smith G, Smith AJ, Basu MK. Mast cells in human odontogenic cysts. J Oral Pathol Med. 1989; 18: 274-28.
|
